Ondansetron, Ranitidine

Ondansetron and Ranitidine is a combination medication used to treat symptoms associated with gastroesophageal reflux disease (GERD) and certain types of nausea and vomiting. Ondansetron is a selective 5-HT3 receptor antagonist that works by blocking the action of serotonin, a chemical in the body that can cause nausea and vomiting. Ranitidine is a histamine H2-receptor antagonist that reduces the production of stomach acid, which can help alleviate symptoms of GERD and other stomach-related issues.
This combination medication is particularly useful for individuals experiencing both nausea or vomiting and acid reflux symptoms, as it addresses both the underlying causes and the resulting symptoms. Ondansetron and Ranitidine can be prescribed by healthcare professionals for short-term use, ensuring patient safety and effective relief of the targeted symptoms.